U.S. Recommends ‘Pause’ For J&J Vaccine Over Blood Clot Reports

The Centers for Disease Control and Prevention and the Food and Drug Administration have recommended a pause in Johnson and Johnson COVID vaccines’ because of clots in seven women several days after receiving the vaccination. One woman died. They have given nearly seven million doses of the J&J vaccine. Federal distribution channels, including mass vaccination sites, will pause the use of the J&J shot. They expect states and other providers to follow. The pause in the administration of the J&J vaccine is a recommendation, not a mandate, and they have found no such problems with the Phizer or Moderna vaccines.